openPR Logo
Press release

Global Next Generation Diabetes Therapy and Drug Delivery Market Expected to Surpass USD 35.76 Billion by 2032, with Collaborations Fueling Breakthroughs

07-02-2024 10:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Dataintelo

/ PR Agency: Dataintelo
Dataintelo

Dataintelo

The global Next Generation Diabetes Therapy and Drug Delivery market, currently valued at USD 10.53 Billion as of 2023, is projected to skyrocket to USD 35.76 Billion by 2032, with a CAGR of 14.1% for the period of 2024 to 2032, according to a report recently published by Dataintelo. Driving this remarkable growth is an escalating prevalence of diabetes around the world and significant advancements in drug delivery technologies.

Today, there is an unprecedented level of awareness and education surrounding diabetes and its management strategies, which is fueling market growth. As a result of various education initiatives and campaigns, patients and healthcare providers are becoming more cognizant of the benefits of advanced therapies and drug delivery systems. In turn, this heightened awareness is anticipated to contribute to higher adoption rates of newfangled technologies, subsequently fostering market growth and enhancing patient outcomes.

Collaboration efforts between pharmaceutical companies, tech firms, and healthcare providers are playing a pivotal role in driving the next generation diabetes therapy and drug delivery market forward. Joint ventures of this nature leverage collective expertise and resources to develop state-of-the-art diabetes therapies and delivery systems. As such collaborations hasten the development and commercialization of advanced therapeutic solutions, they simultaneously boost growth and competitiveness within the market

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/81334

๐“๐ก๐ข๐ฌ ๐ข๐ฌ ๐จ๐ง๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฆ๐จ๐ฌ๐ญ ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ง๐ ๐œ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ:

The next generation diabetes therapy and drug delivery market has been segmented on the basis of๐๐ซ๐จ๐๐ฎ๐œ๐ญ ๐“๐ฒ๐ฉ๐ž
โ— Insulin Delivery Devices
โ— Continuous Glucose Monitoring Systems
โ— Artificial Pancreas System

๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐“๐ฒ๐ฉ๐ž
โ— Insulin
โ— Non-insulin

๐€๐ ๐ž ๐†๐ซ๐จ๐ฎ๐ฉ
โ— Adult
โ— Geriatric
โ— Pediatric

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง
โ— Type 1 Diabetes
โ— Type 2 Diabetes
โ— Gestational Diabetes

๐„๐ง๐-๐ฎ๐ฌ๐ž๐ซ
โ— Hospitals
โ— Home Healthcare
โ— Ambulatory Surgical Centers
โ— Specialty Diabetes Centers

๐‘๐ž๐ ๐ข๐จ๐ง
โ— Asia Pacific
โ— North America
โ— Latin America
โ— Europe
โ— Middle East & Africa

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ
โ— Abbott Laboratories
โ— BD
โ— Dexcom, Inc.
โ— ๐„๐ฅ๐ข ๐‹๐ข๐ฅ๐ฅ๐ฒ ๐š๐ง๐ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ
โ— Insulet Corporation
โ— Medtronic plc
โ— Novo Nordisk A/S
โ— ๐‘๐จ๐œ๐ก๐ž ๐ƒ๐ข๐š๐›๐ž๐ญ๐ž๐ฌ ๐‚๐š๐ซ๐ž, ๐ˆ๐ง๐œ.
โ— Sanofi
โ— Tandem Diabetes Care, Inc.



The next generation diabetes therapy and drug delivery market has been segmented into multiple categories with broad scope. These categories include product type, therapy type, age group, application, end-user, region, and key players.

Under product type, the market is divided into insulin delivery devices such as insulin pens, insulin pumps and insulin patches, continuous glucose monitoring systems, and artificial pancreas system. The therapy type is bifurcated into insulin therapy and non-insulin therapy. Moreover, the market segmentation, based on age-group, includes adult, pediatric, and geriatric age groups. The application stratum differentiates the market for Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. When it comes to end-users, the market can be divided amongst hospitals, home healthcare, ambulatory surgical centers, and specialty diabetes centers.

The regional analysis of the next generation diabetes therapy and drug delivery market reveals its spread across Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. These territories propose varying levels of market penetration, based on factors such as GDP, public healthcare infrastructure, public awareness about diabetes, prevalence rate of diabetes, and research and development interest in the diabetes care sector.

Key players dominating the market regionally and globally include Abbott Laboratories, BD, Dexcom, Inc., Eli Lilly and Company, Insulet Corporation, Medtronic plc, Novo Nordisk A/S, Roche Diabetes Care, Inc., Sanofi, and Tandem Diabetes Care, Inc. These corporations, big and small, play a significant role in shaping the diabetes care market through innovative product manufacturing, competitive pricing, local outreach, research in advanced diabetes care, and more

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/81334

Market Drivers:

1. Rising prevalence of diabetes: The increasing number of people with diabetes worldwide is driving the demand for next-generation diabetes therapy and drug delivery systems.

2. Technological advancements: The introduction of innovative technologies like smart insulin pens, insulin patches, CGMs (Continuous Glucose Monitors), and insulin pumps is propelling the growth of this market.

3. Growing awareness and education about diabetes: Increasing efforts in spreading awareness and education about diabetes amongst the masses, calling for efficient management solutions, is also a significant market driver.

4. Increasing geriatric population: The aging population has higher susceptibility to chronic diseases like diabetes, driving the demand for advanced and effective diabetic treatments.

5. Government initiatives: Government authorities worldwide are introducing health initiatives and funding research and development in diabetes management, propelling market growth.

Market Opportunities:

1. Emerging markets: Developing countries present tremendous opportunities due to the rising incidence of diabetes, growing population, and increasing disposable income.

2. Personalized treatment: Advancements in personalized medicine can provide significant opportunities in tailoring diabetes therapy and drug delivery systems to individual patients for improved outcomes.

3. Non-invasive drug delivery systems: The development and commercialization of non-invasive delivery systems, like inhalable or oral insulin, opens up new growth avenues.

4. Artificial intelligence and machine learning: Incorporation of AI and machine learning in diabetes management could revolutionize the way diabetes is monitored and treated, presenting considerable opportunities.

5. Digital health solutions: The integration of digital health solutions like telemedicine, mobile apps, and IoT-based devices in the management of diabetes could offer significant expansion prospects

๐˜๐จ๐ฎ ๐œ๐š๐ง ๐๐ข๐ซ๐ž๐œ๐ญ๐ฅ๐ฒ ๐›๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐Ÿ๐ซ๐จ๐ฆ: https://dataintelo.com/checkout/81334

Who should buy this report:

1. Business Owners and Executives: These individuals can utilize the report to make informed decisions about upcoming market trends, opportunities, and threats.

2. Market Analysts & Consultants: Professionals in this field can use these reports to gather essential market insights and incisive data for their research.

3. Marketing and Sales Executives: These individuals can use the data from the report to understand customer behavior and preferences, consequently helping in strategizing their sales and marketing plans.

4. Research and Development Professionals: These individuals can use the report to monitor market trends and to determine areas where there might be a need for innovation or improvement.

5. Investors: These individuals can use the report to make strategic investment decisions.

Good things about Dataintelo:

1. Comprehensive Reports: Dataintelo provides detailed and comprehensive market research reports, giving users an in-depth understanding of the market.

2. Accurate Data: The data provided by Dataintelo is gathered from multiple primary and secondary sources, ensuring high data accuracy.

3. Experienced Analysts: Dataintelo boasts of experienced analysts who have a thorough understanding of various markets, ensuring the provision of insightful data.

4. Updated Information: Dataintelo ensures that their database and the market reports are regularly updated with the most recent market trends and developments.

5. Customization: Dataintelo offers customization option in their reports to cater the specific needs of their clientele.

6. 24/7 Customer Service: Dataintelo offers round-the-clock customer service, ensuring that all user queries and issues are addressed promptly

Contact Us :
Dataintelo
Name - Alex Mathews
Phone No.: +1 909 414 1393
Email - sales@dataintelo.com
Website - https://dataintelo.com
Address - 500 East E Street, Ontario, CA 91764, United States.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐œ๐š๐ง ๐›๐ž ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐ž๐ ๐š๐ฌ ๐ฉ๐ž๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ง๐ž๐ž๐.

๐„๐ฆ๐š๐ข๐ฅ ๐ฎ๐ฌ ๐จ๐ง - ๐ฌ๐š๐ฅ๐ž๐ฌ@๐๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ.๐œ๐จ๐ฆ

๐€๐›๐จ๐ฎ๐ญ ๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ:

๐ƒ๐š๐ญ๐š๐ข๐ง๐ญ๐ž๐ฅ๐จ boasts extensive experience in creating tailored Market research reports across diverse industry verticals. With in-depth Market analysis, creative business strategies for new entrants, and insights into the current Market scenario, our reports undergo intensive primary and secondary research, interviews, and consumer surveys.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Next Generation Diabetes Therapy and Drug Delivery Market Expected to Surpass USD 35.76 Billion by 2032, with Collaborations Fueling Breakthroughs here

News-ID: 3561495 • Views: โ€ฆ

More Releases from Dataintelo

Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of XX%, Segmented by Type, Manufacturing Process, Application, and More, Reveals Dataintelo Report
Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of โ€ฆ
Dataintelo has recently unveiled a comprehensive analysis on the Carbon Carbon Composite Brake Disc Market in its latest report. The research, which is segmented by Type (2D C/C composite, 2.5D C/C composite, 3D C/C composite), by Manufacturing Process (Blow Moulding, Injection Moulding) and by Application (Motorsport, Aerospace, Heavy Vehicles), among other factors, anticipates the market to grow at a significant CAGR of XX% during the forecast period. The report considersโ€ฆ
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in Dataintelo's Latest Research Report Covering In-Depth Analysis of Leading Players and Key Sectors
AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in โ€ฆ
Dataintelo has recently published a comprehensive study on the AR Optical Waveguide Module Market, revealing a forecast annual growth rate (CAGR) of XX%. The report is detailed and breaks down its research by aspects such as Light Detection (Infrared, Ultraviolet, Visible Light), Waveguide Type (Planar Waveguide, Channel Waveguide), Material Type (Polymer, LiNbO3, Glass, Silicon), Application (Telecommunication, Healthcare, Industrial, Aerospace and Defense), and Component (Input/Output Coupler, Waveguide Core, Cladding). The report segmentsโ€ฆ
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Players ABB Group, Yaskawa Electric Corporation, and Fanuc Corporation
6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Pla โ€ฆ
In a newly published report from Dataintelo, it is revealed that the 6-Axis Robots Market is projected to experience a substantial growth, marking a significant CAGR in the forecast period. The comprehensive study is segmented by type, including Articulated, Cylindrical, Spherical, and Cartesian robots, and by application, encompassing Material Handling, Welding, Painting, and Assembly amongst others. Additionally, it explores various end-use industries, such as Automotive, Electrical and Electronics, Metals andโ€ฆ
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study on Product Types, Applications, End-users, and Key Players
XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study โ€ฆ
In an insightful investigation of the Mesotherapy Market, Dataintelo unveils a comprehensive analysis of the key growth markers, restraints, and business prospects that will shape the industry dynamics in the coming years. The report is segmented by Product Type (Plant Extracts, Hormones, Enzymes, Vitamins, Others), by Application (Non-Surgical Liposuction, Body Contouring, Hair Restoration, Others), by End-user (Hospitals, Speciality Clinics, Aesthetic Centers), and by Technique (Nappage, Point by Point, Mesoperfusion, Mesolift,โ€ฆ

All 4 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For โ€ฆ
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billionโ€ฆ
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, โ€ฆ
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challengesโ€ฆ
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
Theย Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations.ย This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Marketโ€ฆ
Reverse Diabetes with Dr. Merrittโ€™s Diabetes Reversal Recipe
[November 26, 2020] โ€“ People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center inโ€ฆ
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl โ€ฆ
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitativeโ€ฆ
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the endโ€ฆ